CN109369769B - Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris - Google Patents
Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris Download PDFInfo
- Publication number
- CN109369769B CN109369769B CN201811246837.9A CN201811246837A CN109369769B CN 109369769 B CN109369769 B CN 109369769B CN 201811246837 A CN201811246837 A CN 201811246837A CN 109369769 B CN109369769 B CN 109369769B
- Authority
- CN
- China
- Prior art keywords
- saponins
- water
- ethanol
- monomer
- eluted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000178 monomer Substances 0.000 title claims abstract description 32
- 241001521901 Tribulus lanuginosus Species 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims abstract description 11
- 229930182490 saponin Natural products 0.000 claims abstract description 41
- 150000007949 saponins Chemical class 0.000 claims abstract description 41
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 37
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 20
- 239000011347 resin Substances 0.000 claims abstract description 13
- 229920005989 resin Polymers 0.000 claims abstract description 13
- 238000001179 sorption measurement Methods 0.000 claims abstract description 12
- 239000012141 concentrate Substances 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 73
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 55
- 239000000243 solution Substances 0.000 claims description 40
- 235000017709 saponins Nutrition 0.000 claims description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 27
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 22
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 16
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 claims description 16
- 238000000926 separation method Methods 0.000 claims description 11
- 239000003208 petroleum Substances 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000004809 thin layer chromatography Methods 0.000 claims description 9
- VFCLSWRBHRZGHH-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde ethanol Chemical compound CCO.CN(C)C1=CC=C(C=O)C=C1 VFCLSWRBHRZGHH-UHFFFAOYSA-N 0.000 claims description 8
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 claims description 8
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 5
- 238000012360 testing method Methods 0.000 claims description 5
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 claims description 3
- 150000005856 steroid saponins Chemical class 0.000 claims 4
- 238000010790 dilution Methods 0.000 claims 1
- 239000012895 dilution Substances 0.000 claims 1
- 238000007689 inspection Methods 0.000 claims 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 abstract description 11
- 238000011160 research Methods 0.000 abstract description 3
- 238000010828 elution Methods 0.000 abstract description 2
- 125000004836 hexamethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[*:1] 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000003960 organic solvent Substances 0.000 description 10
- 238000000105 evaporative light scattering detection Methods 0.000 description 6
- 229930002600 steroidal saponin Natural products 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical group O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 2
- GQJDMLOYAFRRDZ-ZSZANOKASA-N (1R,2S,4S,5'R,6R,7S,8R,9S,12S,13S,18S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane]-10,16-dione Chemical compound C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5CC(CC[C@]5(C)[C@H]4CC([C@]23C)=O)=O)O[C@]11CC[C@@H](C)CO1 GQJDMLOYAFRRDZ-ZSZANOKASA-N 0.000 description 1
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000819233 Tribulus <sea snail> Species 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- -1 filter Substances 0.000 description 1
- GQJDMLOYAFRRDZ-OBFAVMMJSA-N hecogenone Natural products O=C1[C@]2(C)[C@H]3[C@H](C)[C@@]4(O[C@H]3C[C@H]2[C@@H]2[C@@H]([C@]3(C)[C@H](CC(=O)CC3)CC2)C1)OC[C@H](C)CC4 GQJDMLOYAFRRDZ-OBFAVMMJSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 229940047183 tribulus Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Abstract
本发明公开了一种从蒺藜茎叶中提取分离海柯酮单体的方法,属于天然药物化学研究领域。本发明以蒺藜茎叶为原料经有机溶剂提取、过滤、浓缩、浓缩液用水稀释后过大孔吸附树脂柱吸附,先用低浓度有机溶剂的水溶液进行洗脱后再高浓度有机溶剂的水溶液进行洗脱,得到含有海柯酮单体的螺甾总皂苷,取螺甾总皂苷进行硅胶柱层析分离,得到海柯酮单体。本发明的制备方法提取效率高,操作简单,适合工业化生产,获得的海柯酮单体纯度高,可用于制备药物组合物及其他产品。The invention discloses a method for extracting and separating hecodone monomers from stems and leaves of Tribulus terrestris, and belongs to the field of natural medicinal chemistry research. In the present invention, the stems and leaves of Tribulus terrestris are used as raw materials to extract, filter, concentrate, and dilute the concentrated solution with water, and then adsorb through a macroporous adsorption resin column. Elution is carried out to obtain the total spirol saponin containing the hexamethylene monomer, and the total spirol saponin is taken and separated by silica gel column chromatography to obtain the hexacodone monomer. The preparation method of the invention has high extraction efficiency, simple operation, and is suitable for industrial production.
Description
技术领域technical field
本发明涉及一种从蒺藜茎叶中提取分离海柯酮单体的方法,属于天然药物化学研究领域。The invention relates to a method for extracting and separating hecodone monomers from stems and leaves of Tribulus terrestris, and belongs to the field of natural medicinal chemistry research.
背景技术Background technique
蒺藜(Tribulus terretris L.)为蒺藜科蒺藜属植物,是一年生或多年生草本植物。茎由基部分枝,平铺在地面上、枝长可达30-60cm,叶为羽状复叶、形小且尖,果实由5个分果瓣组成,呈放射状排列,直径7-12mm。其为传统中药,又名白蒺藜、刺蒺藜、蒺藜子、硬蒺藜。性味辛、苦、微温、有小毒、入肝、肺经,具有平肝解郁、活血、明目、止痒等功效,主要用于头疼眩晕、乳闭乳痛、风疹瘙痒等症。药理研究表明,蒺藜具有抗菌、抗癌、利尿等作用,尤其在防治心脑血管疾病方面有较突出的疗效。Tribulus terretris L. is an annual or perennial herb. The stem is branched from the base and spreads flat on the ground. The length of the branches can reach 30-60cm. The leaves are pinnately compound leaves, small and pointed. It is a traditional Chinese medicine, also known as Tribulus terrestris, Tribulus terrestris, Tribulus terrestris, and Tribulus terrestris. It is acrid, bitter, slightly warm in nature, has a small poison, enters the liver and lung meridians, and has the functions of calming the liver and relieving depression, promoting blood circulation, improving eyesight, and relieving itching. Pharmacological studies have shown that Tribulus terrestris has antibacterial, anticancer, and diuretic effects, especially in the prevention and treatment of cardiovascular and cerebrovascular diseases.
到目前为止人们从蒺藜中分得多种甾体皂苷,包括呋甾型甾体皂苷和螺甾型甾体皂苷,这些皂苷是蒺藜的主要有效成分。现代研究发现蒺藜茎叶中甾体皂苷的含量及种类与果实相似,蒺藜茎叶提取物也具有改善心脑血管、降血脂、抗真菌等作用。海柯酮(Hecogenone)是蒺藜茎叶中含有的一种螺甾型甾体皂苷,具有清除羟基自由基、抑制酪氨酸酶以及抗真菌的作用。So far, a variety of steroidal saponins have been isolated from Tribulus terrestris, including furosteric steroidal saponins and spirosteroidal steroidal saponins, which are the main active components of Tribulus terrestris. Modern research has found that the content and types of steroidal saponins in the stems and leaves of Tribulus terrestris are similar to those in fruits, and the extracts from stems and leaves of Tribulus terrestris also have the effects of improving cardiovascular and cerebrovascular, lowering blood lipids, and antifungal. Hecogenone is a spirosteroidal steroidal saponin contained in the stems and leaves of Tribulus terrestris, which has the functions of scavenging hydroxyl radicals, inhibiting tyrosinase and antifungal.
发明内容SUMMARY OF THE INVENTION
本发明提供了一种从蒺藜茎叶中提取分离海柯酮单体的方法。The invention provides a method for extracting and separating hecodone monomer from stems and leaves of Tribulus terrestris.
为实现上述目的,本发明采用了以下技术方案:To achieve the above object, the present invention has adopted the following technical solutions:
以蒺藜茎叶为原料用有机溶剂的水溶液进行提取、过滤、浓缩、浓缩液用水稀释后过大孔吸附树脂柱吸附,先用低浓度有机溶剂的水溶液洗脱后再用高浓度有机溶剂的水溶液进行洗脱,TLC跟踪监测,得到螺甾总皂苷,取螺甾总皂苷进行硅胶柱层析分离,最终得到海柯酮单体。Using the stems and leaves of Tribulus terrestris as raw materials, extract, filter, concentrate, and dilute the concentrated solution with water, and then adsorb through a macroporous adsorption resin column, first eluate with an aqueous solution of a low-concentration organic solvent, and then use an aqueous solution of a high-concentration organic solvent. Elution is carried out, followed by TLC monitoring to obtain total spirosterin saponins, and the total spirosterol saponins are taken for separation by silica gel column chromatography, and finally the hexamethylene monomer is obtained.
所述蒺藜茎叶的提取方法为:取将干燥的蒺藜茎叶粉碎,用有机溶剂水溶液回流提取三次,合并三次提取液,回收溶剂。有机溶剂的水溶液为丙酮水、甲醇水或者乙醇水,优选70%-85%的丙酮水、甲醇水或者乙醇水。The method for extracting the stems and leaves of Tribulus terrestris is as follows: take and pulverize the stems and leaves of Tribulus terrestris, extract three times by refluxing with an aqueous organic solvent solution, combine the three extracts, and recover the solvent. The aqueous solution of the organic solvent is acetone water, methanol water or ethanol water, preferably 70%-85% acetone water, methanol water or ethanol water.
所述的大孔吸附树脂选自AB-8、D103、D101、HP20的一种或它们的两种或两种以上的混合树脂。The macroporous adsorption resin is selected from one of AB-8, D103, D101, HP20 or a mixed resin of two or more of them.
所述的有机溶剂选自乙醇、甲醇、丙酮或它们的两种或两种以上混合溶剂。The organic solvent is selected from ethanol, methanol, acetone or two or more mixed solvents thereof.
所述的低浓度有机溶剂的水溶液是体积百分比浓度小于等于40%的水溶液。The aqueous solution of the low-concentration organic solvent is an aqueous solution with a volume percent concentration of less than or equal to 40%.
所述的高浓度有机溶剂的水溶液是体积百分比浓度大于40%的水溶液。The aqueous solution of the high-concentration organic solvent is an aqueous solution with a volume percent concentration greater than 40%.
所述的将蒺藜茎叶提取物用大孔吸附树脂吸附后,是先用体积百分比浓度小于15%有机溶剂的水溶液洗脱,然后用大于15%至小于40%的有机溶剂的水溶液洗脱得到呋甾型甾体皂苷,最后用体积百分比浓度大于40%的有机溶剂的水溶液洗脱,得到含有海柯酮单体的螺甾总皂苷。After the tribulus terrestris stem and leaf extract is adsorbed with macroporous adsorption resin, it is firstly eluted with an aqueous solution of an organic solvent whose volume percentage concentration is less than 15%, and then eluted with an aqueous solution of an organic solvent whose volume percentage concentration is less than 15% to less than 40%. Furosteroid saponins are finally eluted with an aqueous solution of an organic solvent with a concentration of more than 40% by volume to obtain total spirosteroidal saponins containing hecodone monomer.
螺甾总皂苷柱层析是以乙酸乙酯:乙醇:水为洗脱剂,优选体积比为5:3:1的乙酸乙酯:乙醇:水为流动相进行硅胶柱层析分离,得到含有海柯酮单体的组分B后;将组分B以石油醚:乙酸乙酯:乙醇:水为流动相再次进行硅胶柱层析分离,得到海柯酮单体,优选体积比为6:1:1:0.1。本发明制备方法工艺合理、提取效率高,操作简单,海柯酮纯度高,适合工业化生产。The total spirosterol saponins column chromatography uses ethyl acetate: ethanol: water as the eluent, preferably ethyl acetate: ethanol: water with a volume ratio of 5: 3: 1 as the mobile phase to perform silica gel column chromatography separation to obtain a After the component B of the heikodone monomer; the component B is separated by silica gel column chromatography with petroleum ether: ethyl acetate: ethanol: water as the mobile phase again to obtain the heikodone monomer, and the preferred volume ratio is 6: 1:1:0.1. The preparation method of the invention has the advantages of reasonable process, high extraction efficiency, simple operation and high purity of the hecodone, and is suitable for industrial production.
本发明获得的海柯酮单体可用于制备药物组合物及其他产品。The hecodone monomer obtained by the present invention can be used for preparing pharmaceutical compositions and other products.
具体实施方式Detailed ways
以下对本发明的优选实施例进行说明。应当理解,此处所描述的优选实施例仅用于说明和解释本发明,并不用于限定本发明。Preferred embodiments of the present invention will be described below. It should be understood that the preferred embodiments described herein are only used to illustrate and explain the present invention, but not to limit the present invention.
实施例1Example 1
取干燥的蒺藜茎叶5Kg粉碎,用70%乙醇水溶液回流提取三次,乙醇水溶液用量分别为10、8、6倍(W/V),回流时间为3h、2h、1h,合并三次提取液,回收溶剂至无乙醇味。浓缩液加水稀释,稀释液过AB-8大孔吸附树脂吸附,用去离子水洗至无色,用8倍柱体积的35%的乙醇溶液洗脱,将洗脱液浓缩后用氯仿-甲醇-水(8:4:0.9)为展开剂进行薄层层析检验,用A试剂(50ml醋酸使0.5ml茴香醛溶解,加硫酸1ml)和E试剂(1%对二甲氨基苯甲醛乙醇溶液:浓盐酸(4;1))显色,结果显示此时洗脱的成分是呋甾型甾体皂苷,将呋甾型甾体皂苷洗脱完全后再用80%乙醇溶液将螺甾皂苷洗脱,减压回收溶剂,干燥,获得螺甾总皂苷。Take 5Kg of dried Tribulus terrestris stems and leaves and pulverize, and extract three times with 70% ethanol aqueous solution. Solvent until there is no ethanol odor. The concentrated solution was diluted with water, the diluted solution was adsorbed by AB-8 macroporous adsorption resin, washed with deionized water until colorless, eluted with 35% ethanol solution of 8 times the column volume, and the eluate was concentrated with chloroform-methanol- Water (8:4:0.9) was used as the developing solvent to carry out thin layer chromatography test, and reagent A (50ml acetic acid was used to dissolve 0.5ml anisaldehyde, and 1ml sulfuric acid was added) and reagent E (1% p-dimethylaminobenzaldehyde ethanol solution: Concentrated hydrochloric acid (4; 1)) developed color, the result showed that the eluted component at this time was fururosteroid saponin, after the fururosteroid saponin was completely eluted, the spirosteroid saponin was eluted with 80% ethanol solution , the solvent was recovered under reduced pressure and dried to obtain total spirosterol saponins.
取螺甾总皂苷30g,以乙酸乙酯:乙醇:水=5:3:1(体积比)为流动相进行硅胶柱层析分离,得到含有海柯酮单体的组分B 10.1g;将组分B以石油醚:乙酸乙酯:乙醇:水(6:1:1:0.1,体积比)为流动相再次进行硅胶柱层析分离,得到海柯酮单体。Take 30 g of total spirosterol saponins, and use ethyl acetate: ethanol: water = 5:3:1 (volume ratio) as the mobile phase for separation by silica gel column chromatography to obtain 10.1 g of component B containing hecodone monomer; Component B is again separated by silica gel column chromatography with petroleum ether: ethyl acetate: ethanol: water (6:1:1:0.1, volume ratio) as the mobile phase to obtain the hecodone monomer.
得到的海柯酮单体用NMR确定了结构,HPLC-ELSD检测其纯度为99.5%。The structure of the obtained hecodone monomer was confirmed by NMR, and its purity was 99.5% detected by HPLC-ELSD.
海柯酮的核磁数据如下The NMR data of hecodone are as follows
13C NMR(C5D5N,150MHz)δc:38.12(C-1),38.02(C-2),209.72(C-3),44.7(C-4),46.37(C-5),28.75(C-6),31.43(C-7),34.31(C-8),54.96(C-9),36.37(C-10),38.12(C-11),212.44(C-12),55.47(C-13),55.77(C-14),31.53(C-15),79.75(C-16),54.42(C-17),16.19(C-18),10.88(C-19),42.74(C-20),14.01(C-21),109.41(C-22),31.89(C-23),29.31(C-24),30.63(C-25),67.04(C-26),17.40(C-27)。 13 C NMR (C 5 D 5 N, 150 MHz) δc: 38.12 (C-1), 38.02 (C-2), 209.72 (C-3), 44.7 (C-4), 46.37 (C-5), 28.75 (C-6), 31.43(C-7), 34.31(C-8), 54.96(C-9), 36.37(C-10), 38.12(C-11), 212.44(C-12), 55.47( C-13), 55.77(C-14), 31.53(C-15), 79.75(C-16), 54.42(C-17), 16.19(C-18), 10.88(C-19), 42.74(C -20), 14.01(C-21), 109.41(C-22), 31.89(C-23), 29.31(C-24), 30.63(C-25), 67.04(C-26), 17.40(C-20) 27).
1H NMR(C5D5N,600MHz)δH:4.37(1H,m H-16),3.48(1H,dd J=10.7Hz H-26),3.35(1H,t J=10.8Hz H-26),2.66-1.06(25H,m),0.82(3H,s H-18),1.00(3H,s H-19),1.24(3H,d J=6.1Hz H-21),0.57(3H,d J=6.3Hz H-27)。 1 H NMR (C 5 D 5 N, 600 MHz) δ H : 4.37 (1H, m H-16), 3.48 (1 H, dd J=10.7 Hz H-26), 3.35 (1 H, t J=10.8 Hz H- 26), 2.66-1.06 (25H, m), 0.82 (3H, s H-18), 1.00 (3H, s H-19), 1.24 (3H, d J=6.1Hz H-21), 0.57 (3H, d J = 6.3 Hz H-27).
HPLC-ELSD色谱条件如下The HPLC-ELSD chromatographic conditions are as follows
色谱柱:Agilent Eclipse XDB-C18(ODS,4.6×250nm,5μm)Column: Agilent Eclipse XDB-C18 (ODS, 4.6×250nm, 5μm)
流动相:乙睛-水(45:55);流速:1L/min;柱温:30℃Mobile phase: acetonitrile-water (45:55); flow rate: 1L/min; column temperature: 30°C
进样量:20μL;ELSD检测器漂移管温度98℃;撞击器状态:关闭。Injection volume: 20 μL; ELSD detector drift tube temperature 98°C; Impactor status: off.
载气压力:0.45Mpa雾化器流速:2.6L/min放大倍数:1.0倍Carrier gas pressure: 0.45Mpa Nebulizer flow rate: 2.6L/min Magnification: 1.0 times
实施例2Example 2
取干燥的蒺藜茎叶5Kg粉碎,用70%甲醇水溶液回流提取三次,甲醇水溶液用量分别为10、8、6倍(W/V),回流时间为3h、2h、1h,合并三次提取液,回收溶剂至无醇味。浓缩液加水稀释,稀释液过D101大孔吸附树脂吸附,用去离子水洗至无色,用8倍柱体积的30%的甲醇溶液洗脱,将洗脱液浓缩后用氯仿-甲醇-水(8:4:0.9)为展开剂进行薄层层析检验,用A试剂(50ml醋酸使0.5ml茴香醛溶解,加硫酸1ml)和E试剂(1%对二甲氨基苯甲醛乙醇溶液:浓盐酸(4;1))显色,结果表明此时洗脱下来的成分是呋甾型甾体皂苷,将呋甾型甾体皂苷洗脱完全后再用80%甲醇溶液将螺甾皂苷洗脱,减压回收溶剂,干燥,获得螺甾总皂苷。Take 5Kg of dried stems and leaves of Tribulus terrestris and pulverize, and extract three times with 70% methanol aqueous solution. The amount of methanol aqueous solution is 10, 8, and 6 times (W/V), respectively. Solvent to no alcohol odor. The concentrated solution was diluted with water, the diluted solution was adsorbed by D101 macroporous adsorption resin, washed with deionized water until colorless, eluted with 30% methanol solution of 8 times the column volume, and the eluent was concentrated with chloroform-methanol-water ( 8:4:0.9) as the developing agent, carry out thin layer chromatography test, use reagent A (50ml acetic acid to dissolve 0.5ml anisaldehyde, add 1ml sulfuric acid) and reagent E (1% p-dimethylaminobenzaldehyde ethanol solution: concentrated hydrochloric acid) (4; 1)) color development, the results show that the components eluted at this time are furosteroid saponins. After the furosteroid saponins are completely eluted, the spirosteroid saponins are eluted with 80% methanol solution. The solvent was recovered under reduced pressure and dried to obtain total spirosterol saponins.
取螺甾总皂苷30g,以乙酸乙酯:乙醇:水(5:3:1,体积比)为流动相进行硅胶柱层析分离,得到含有海柯酮单体的组分B9.2g;将组分B以石油醚:乙酸乙酯:乙醇:水(6:1:1:0.1,体积比)为流动相再次进行硅胶柱层析分离,得到海柯酮单体。Take 30 g of total spirosterol saponins, and use ethyl acetate: ethanol: water (5:3:1, volume ratio) as the mobile phase to carry out silica gel column chromatography separation to obtain 9.2 g of component B containing hecodone monomer; Component B is again separated by silica gel column chromatography with petroleum ether: ethyl acetate: ethanol: water (6:1:1:0.1, volume ratio) as the mobile phase to obtain the hecodone monomer.
HPLC-ELSD检测,其纯度为99.2%。HPLC-ELSD detection, its purity is 99.2%.
实施例3Example 3
取干燥的蒺藜茎叶5Kg并粉碎,用85%丙酮水溶液回流提取三次,丙酮水溶液用量分别为10、8、6倍(W/V),回流时间为3h、2h、1h,合并三次提取液,回收溶剂。浓缩液加水稀释,稀释液过D4020大孔吸附树脂吸附,用去离子水洗至无色,用8倍柱体积的25%的丙酮溶液洗脱,将洗脱液浓缩后用氯仿-甲醇-水(8:4:0.9)为展开剂进行薄层层析检验,用A试剂(50ml醋酸使0.5ml茴香醛溶解,加硫酸1ml)和E试剂(1%对二甲氨基苯甲醛乙醇溶液:浓盐酸(4;1))显色,结果表明此时洗脱的成分是呋甾型甾体皂苷,将呋甾型甾体皂苷洗脱完全后再用85%丙酮溶液将螺甾皂苷洗脱,减压回收溶剂,干燥,获得螺甾总皂苷。Take 5Kg of dried stems and leaves of Tribulus terrestris and pulverize, and extract three times with 85% acetone aqueous solution. Solvent recovery. The concentrated solution was diluted with water, the diluted solution was adsorbed by D4020 macroporous adsorption resin, washed with deionized water until colorless, eluted with 25% acetone solution of 8 times the column volume, and the eluent was concentrated with chloroform-methanol-water ( 8:4:0.9) as the developing agent, carry out thin layer chromatography test, use reagent A (50ml acetic acid to dissolve 0.5ml anisaldehyde, add 1ml sulfuric acid) and reagent E (1% p-dimethylaminobenzaldehyde ethanol solution: concentrated hydrochloric acid) (4; 1)) color development, the results show that the eluted component is furosteroid saponin at this time, after the furosteroid saponin is completely eluted, the spirosteroid saponin is eluted with 85% acetone solution. The solvent is recovered under pressure and dried to obtain total spirosterol saponins.
取螺甾总皂苷30g,以乙酸乙酯:乙醇:水(5:3:1,体积比)为流动相进行硅胶柱层析分离,得到含有海柯酮单体的组分B9.5g;将组分B以石油醚:乙酸乙酯:乙醇:水(6:1:1:0.1,体积比)为流动相再次进行硅胶柱层析分离,得到海柯酮单体。Take 30 g of total spirosterol saponins, and use ethyl acetate: ethanol: water (5:3:1, volume ratio) as the mobile phase to separate by silica gel column chromatography to obtain 9.5 g of component B containing hecodone monomer; Component B is again separated by silica gel column chromatography with petroleum ether: ethyl acetate: ethanol: water (6:1:1:0.1, volume ratio) as the mobile phase to obtain the hecodone monomer.
HPLC-ELSD检测,其纯度为98.0%。HPLC-ELSD detection, its purity is 98.0%.
实施例4Example 4
取干燥的蒺藜茎叶5Kg并粉碎,用90%乙醇水溶液回流提取三次,乙醇水溶液用量分别为10、8、6倍(W/V),回流时间为3h、2h、1h,合并三次提取液,回收溶剂至无乙醇味。浓缩液加水稀释,稀释液过HP20大孔吸附树脂吸附,用去离子水洗至无色,用8倍柱体积的40%的乙醇溶液洗脱,将洗脱液浓缩后用氯仿-甲醇-水(8:4:0.9)为展开剂进行薄层层析检验,用A试剂(50ml醋酸使0.5ml茴香醛溶解,加硫酸1ml)和E试剂(1%对二甲氨基苯甲醛乙醇溶液:浓盐酸(4;1))显色,结果表明此时洗脱的成分是呋甾型甾体皂苷,将呋甾型甾体皂苷洗脱完全后再用95%乙醇溶液将螺甾皂苷洗脱,减压回收溶剂,干燥,获得螺甾总皂苷。Take 5Kg of dry stems and leaves of Tribulus terrestris and pulverize them, extract three times with 90% ethanol aqueous solution, the amount of ethanol aqueous solution is 10, 8, and 6 times (W/V) respectively, and the reflux time is 3h, 2h, 1h, and the three extracts are combined, The solvent is recovered until there is no ethanol odor. The concentrated solution was diluted with water, the diluted solution was adsorbed by HP20 macroporous adsorption resin, washed with deionized water until colorless, eluted with 40% ethanol solution of 8 times the column volume, and the eluent was concentrated with chloroform-methanol-water ( 8:4:0.9) as the developing agent, carry out thin layer chromatography test, use reagent A (50ml acetic acid to dissolve 0.5ml anisaldehyde, add 1ml sulfuric acid) and reagent E (1% p-dimethylaminobenzaldehyde ethanol solution: concentrated hydrochloric acid) (4; 1)) color development, the result shows that the eluted component is furosteroid saponin at this time, after the furosteroid saponin is completely eluted, the spirosteroid saponin is eluted with 95% ethanol solution to reduce The solvent is recovered under pressure and dried to obtain total spirosterol saponins.
取螺甾总皂苷30g,以乙酸乙酯:乙醇:水(5:3:1,体积比)为流动相进行硅胶柱层析分离,,得到含有海柯酮单体的组分B8.5g;将组分B以石油醚:乙酸乙酯:乙醇:水(6:1:1:0.1,体积比)为流动相再次进行硅胶柱层析分离,得到海柯酮单体。Take 30 g of total spirosterol saponins, and use ethyl acetate: ethanol: water (5:3:1, volume ratio) as the mobile phase for separation by silica gel column chromatography to obtain 8.5 g of component B containing hecodone monomer; Component B was separated again by silica gel column chromatography with petroleum ether: ethyl acetate: ethanol: water (6:1:1:0.1, volume ratio) as the mobile phase to obtain the hecodone monomer.
HPLC-ELSD检测,其纯度为97.5%。HPLC-ELSD detection, its purity is 97.5%.
上述实施例仅为本发明的优选实施例而已,并不用于限制本发明,尽管前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。The foregoing embodiments are only preferred embodiments of the present invention, and are not intended to limit the present invention. Although the foregoing embodiments have described the present invention in detail, for those skilled in the art, they can still understand the The recorded technical solutions are modified, or some technical features thereof are equivalently replaced. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included within the protection scope of the present invention.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811246837.9A CN109369769B (en) | 2018-10-23 | 2018-10-23 | Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811246837.9A CN109369769B (en) | 2018-10-23 | 2018-10-23 | Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109369769A CN109369769A (en) | 2019-02-22 |
CN109369769B true CN109369769B (en) | 2020-10-30 |
Family
ID=65401762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811246837.9A Expired - Fee Related CN109369769B (en) | 2018-10-23 | 2018-10-23 | Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109369769B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2408834A (en) * | 1944-05-15 | 1946-10-08 | Parke Davis & Co | Steroidal compounds and methods for obtaining the same |
JP2004323400A (en) * | 2003-04-23 | 2004-11-18 | Mikimoto Pharmaceut Co Ltd | Skin care preparation for external use |
CN107296877A (en) * | 2017-06-09 | 2017-10-27 | 吉林瑞诺科技有限公司 | A kind of preparation method of Longstamen Onion Bulb group saponine |
CN107296818A (en) * | 2017-06-15 | 2017-10-27 | 吉林大学 | A kind of method that total furostanol saponin and total spirostanol saponin are prepared from puncture vine |
-
2018
- 2018-10-23 CN CN201811246837.9A patent/CN109369769B/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN109369769A (en) | 2019-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103193846B (en) | Preparation method of cis-trans isomers of ginsenoside Rk3 and ginsenoside Rh4 | |
CN112300242B (en) | Preparation method of furostanol saponin compound monomer | |
CN101255182B (en) | Extraction separating method for bupleurum root saponin b2 | |
CN108164579A (en) | A kind of method of aerial part extraction separation chonglou saponin H from Paris polyphylla | |
CN109369769B (en) | Method for extracting and separating hecolone monomer from stems and leaves of tribulus terrestris | |
CN101265247B (en) | Method for separating effective constituent butenolide II from astraolylis lancea formalyrata volatile oil | |
CN102558256B (en) | Method for separation and preparation of tenuifolin from polygala tenuifolia | |
CN102532243B (en) | Method for simultaneously preparing multiflora rose glycoside and rose glycoside compounds | |
Eseyin et al. | Isolation and characterization of antioxidant constituents of the fruit of Telfairia occidentalis Hook F (Cucurbitaceae) | |
CN105085534A (en) | Novel skeleton alkaloid compound and extraction separation method thereof | |
CN114790222B (en) | Flavonoids based on epimedium and preparation method thereof | |
CN107513049A (en) | Euphorbia diterpenoids moleplant seed diterpene A preparation method and application | |
CN101062249B (en) | Composition of Anemarrhena extract and Cortex Phellodendri extract and use thereof | |
CN103193855A (en) | Preparation method of cherokee rose fruit saponin monomer | |
CN109336942B (en) | Method for extracting purified panax japonicus saponin VI from ginseng | |
CN114380885B (en) | Two kinds of triterpenoids in xiaohuaqingfengteng and preparation method thereof | |
CN102764320A (en) | Psychotria sp. extract, and preparation method and antineoplastic application thereof | |
CN103570795A (en) | Preparation method of tripterine | |
CN107296818A (en) | A kind of method that total furostanol saponin and total spirostanol saponin are prepared from puncture vine | |
CN109053851B (en) | Extract containing ilicin A and extraction method thereof | |
CN109438548B (en) | A kind of preparation method of Dianzhong Lou Pianuoside Pb | |
CN115677816B (en) | Novel furostanol saponin monomer and preparation method thereof | |
CN104530175B (en) | Water chestnut skin extracts the method that separates betulinic acid | |
CN101565445B (en) | Method for preparing high-purity veratramine and jervine | |
CN113501854B (en) | Method for preparing cholesteryl heptadecanoate from slug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20201030 Termination date: 20211023 |